Journal
CELL TRANSPLANTATION
Volume 18, Issue 2, Pages 111-118Publisher
SAGE PUBLICATIONS INC
DOI: 10.3727/096368909788341243
Keywords
Adult stem cells; Progenitors; Placenta; Mesenchymal stromal cells; Transplantation; Cerebral ischemia
Ask authors/readers for more resources
Regenerative medicine is a new field primarily based on the concept of transplanting exogenous or stimulating endogenous stein cells to generate biological substitutes and improve tissue functions. Recently, amnion-derived cells have been reported to have multipotent differentiation ability, and these cells have attracted attention as a novel cell source for cell transplantation therapy. Cells isolated From amniotic membrane can differentiate into all three germ layers, have low immunogenicity and anti-inflammatory function, and do not require the destruction of human embryos for their isolation, thus circumventing the ethical debate commonly associated with the use of human embryonic stern cells. Accumulating evidence now suggests that the amnion, which had been discarded after parturition, is a highly potent transplant material in the field of regenerative medicine. In this report, we review the current progress on the characterization of MSCs derived from the amnion as a remarkable transplantable cell population with therapeutic potential for multiple CNS disorders, especially stroke.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available